Elsevier

The Journal of Emergency Medicine

Volume 15, Issue 2, March–April 1997, Pages 221-230
The Journal of Emergency Medicine

A review of etomidate for rapid sequence intubation in the emergency department

https://doi.org/10.1016/S0736-4679(96)00350-2Get rights and content

Abstract

Currently, there is no one drug that is the agent of choice for induction in rapid sequence intubation in the emergency department (ED). All agents currently used as induction agents in the ED offer distinct advantages for various clinical conditions, but each has a significant side effect profile and specific contraindications that limit its use in many common clinical settings. A review of the data available from the anesthesia literature suggests that etomidate possesses many properties that may make it the agent of choice for rapid sequence intubations in the ED. These advantages include excellent pharmacodynamics, protection from myocardial and cerebral ischemia, minimal histamine release, and a hemodynamic profile that is uniquely stable. Disadvantages include a lack of blunting of sympathetic response to intubation, a high incidence of myoclonus, prominent nausea and vomiting, potential activation of seizures in patients with epileptogenic foci, and impaired glucocorticoid response to stress. Further studies are needed to evaluate the advantages and disadvantages of the use of etomidate for rapid sequence intubation in the ED.

References (162)

  • R Carlos et al.

    Effect of premedication on etomidate anaesthesia

    Br J Anaesthesia

    (1979)
  • HM Meinck et al.

    Neurophysiological effects of etomidate, a new short-acting hypnotic

    Electroencephalogr Clin Neurophysiol

    (1980)
  • M.P. Colvin et al.

    Cardiorespiratory changes following induction of anaesthesia with etomidate in patients with cardiac disease

    Br J Anaesthesia

    (1979)
  • A Doenicke

    Etomidate, a new intravenous hypnotic

    Acta Anesthesiol Belg

    (1974)
  • J.L. Giese et al.

    Etomidate: a new intravenous anesthetic induction agent

    Pharmacotherapy

    (1983)
  • WEI Finlai et al.

    Serum cortisol levels in severely stressed patients

    Lancet

    (1982)
  • R.J. Fragen et al.

    Effects of etomidate on hormonal response to surgical stress

    Anesthesiology

    (1984)
  • R DeCoster et al.

    Effect of etomidate on cortisol biosynthesis: site of action after induction of anesthesia

    Acta Endocrinol

    (1985)
  • R.L. Wagner et al.

    Inhibition of adrenal steroidogenesis by the anaesthetic etomidate

    N Engl J Med

    (1984)
  • B Allolio et al.

    Effect of a single dose of etomidate upo eight major corticosteroid hormones and plasma ACTH

    Clin Endocrinol

    (1985)
  • IM Ledingham et al.

    Etomidate and adrenocortical function [letter]

    Lancet

    (1983)
  • C.S. Deutschman

    Anesthetic considerations in the use of corticosteroids and antibiotics

  • J.G. Reves et al.

    Nonbarbiturate intravenous anesthetics

  • WS Nimmo et al.

    Pharmacoloogy of etomidate

    Contemp Anesthesiol Pract

    (1983)
  • BW Hadzija et al.

    Compatibilty of etomidate, thiopental sodium, and propofol injections with drugs commonly administered during induction of anesthesia

    Am J Health Syst Pharmacol

    (1995)
  • J.W. Dundee et al.

    Etomidate

    Curr Topics Anesthesia

    (1979)
  • MJ Van Hamme et al.

    Pharmacokinetics of etomidate, a new intravenous anesthetic

    Anesthesiology

    (1978)
  • G DeRuiter et al.

    Pharmacokinetics of etomidate in surgical patients

    Arch Int Pharmacodyn Ther

    (1981)
  • G Corssen et al.

    Intravenous anaesthesia and analgesia

  • WEG Meuldermans et al.

    The plasma protien binding and distribution of etomidate in dog, rat, and human blood

    Arch Int Pharmacodyn Ther

    (1976)
  • R.J. Fragen et al.

    Nonopioid intravenous anesthetics

  • J Van Hemelrijck et al.

    Pharmacology of intravenous anesthetic agents

  • J Nauta et al.

    Anaesthetic induction with alfentanil: comparison with thiopental, midazolam, and etomidate

    Can J Anaesthet

    (1983)
  • M.R. Murphy

    Opioids

  • C.E. Famewo et al.

    Clinical trial of etomidate

    Can Anaesthet Soc J

    (1977)
  • H.H. Chiu et al.

    Clinical evaluation of etomidate as an induction agent

    Anaesthesia Intens Care

    (1978)
  • J.B.G Hendry et al.

    Etomidate, a new solvent. Clinical evaluation

    Anaesthesia

    (1977)
  • J.R. Arden et al.

    Increased sensitivity to etomidate in the elderly: initial distribution versus altered brain response

    Anesthesiology

    (1986)
  • DM Linton et al.

    Etomidate as a rectal induction agent. Part II. A clinical study in children

    S Afr Med J

    (1983)
  • MF Thompson et al.

    Anesthesia and intraocular pressure; a comparison of total anesthesia using etomidate with conventional inhalation anesthesia

    Anaesthesia

    (1982)
  • R.K. Mirakhur et al.

    Intra-ocular pressure changes during induction of anaesthesia and tracheal intubation: a comparison of thiopentone and propofol followed by vecuronium

    Anaesthesia

    (1988)
  • JM Berry et al.

    Etomidate myoclonus and the open globe

    Anesthesia Analg

    (1989)
  • C.E. Famewo et al.

    Effect of etomidate on intra-ocular pressure

    Can Anaesthesia Soc J

    (1977)
  • FM Yatsu et al.

    Experimental brain ischemia: protection from irreversible damage with a rapid acting barbituate (methohexital)

    Stroke

    (1972)
  • JD Michenfelder et al.

    Cerebral protection by thiopental during hypoxia

    Anesthesiology

    (1973)
  • A.L. Smith et al.

    Barbiturate protection in acute focal cerebral ischemia

    Stroke

    (1974)
  • JD Michenfelder et al.

    Influence of anesthesitics on metabolic, functional and pathological responses to regional cerebral ischemia

    Stroke

    (1975)
  • JD Michenfelder et al.

    Cerebral protection by barbiturate anesthesia

    Arch Neurol

    (1976)
  • H.H. Batjer

    Cerebral protective effects of etomidate: experimental and clinical aspects

    Cerebrovasc Brain Metab Rev

    (1993)
  • H.J. Hartung

    Intracranial pressure after propofol and thiopental administration in patients with severe head trauma

    Anaesthesist

    (1987)
  • Cited by (174)

    • Resuscitation of the Obstetric Patient

      2023, Emergency Medicine Clinics of North America
    • Hemodynamics in Helicopter Emergency Medical Services (HEMS) Patients Undergoing Rapid Sequence Intubation With Etomidate or Ketamine

      2022, Journal of Emergency Medicine
      Citation Excerpt :

      Airway management is a staple of prehospital emergency medical care, but can be fraught with risks and complications, especially in the undifferentiated prehospital medical or trauma patient (1,2).

    • Diagnosis and Management of Myocarditis: An Evidence-Based Review for the Emergency Medicine Clinician

      2021, Journal of Emergency Medicine
      Citation Excerpt :

      Optimizing preintubation hemodynamics and preload will help mitigate these risks. In patients with a normal or low blood pressure, a lower dose of etomidate or ketamine (i.e., etomidate 0.1 mg/kg i.v. or ketamine 0.1–0.3 mg/kg i.v.) is recommended to reduce the risk of further hemodynamic compromise during induction (19,116,117). Clinicians should consider having vasopressors immediately available in case the blood pressure acutely lowers.

    • The High-Risk Airway

      2020, Emergency Medicine Clinics of North America
    View all citing articles on Scopus

    Pharmacology of Emergency Medicine is coordinated by Richard F. Clark, md, of the University of California, San Diego Medical Center, and the San Diego Regional Poison Center, San Diego, California.

    View full text